335P Resistance to CDK4/6 inhibitors: Clinical practice use of liquid biopsy to identify KRAS-mutations in ctDNA and overexpression of CDK9 in plasma derived exosomes.

Saved in:
Bibliographic Details
Title: 335P Resistance to CDK4/6 inhibitors: Clinical practice use of liquid biopsy to identify KRAS-mutations in ctDNA and overexpression of CDK9 in plasma derived exosomes.
Authors: Raimondi, L.1 (AUTHOR), Pietranera, M.2 (AUTHOR), Spinelli, G.P.1 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS380-S380. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.437